J2248
J2248 – Injection, micafungin sodium, 1 mg · NDC Crosswalk & Billing Units
HCPCS Level II J-code · Medicare Part B drug billing
J-code
● 35 NDCs crosswalked per 1 MG $0.180/unit ASP+6%
📋 J2248 summary
J2248 is a HCPCS Level II J-code used to bill micafungin sodium, 1 mg, billed per 1 MG. The number of billing units to report depends on the dose administered and the NDC/package billed — use the calculator below.
Brand names associated with J2248: Micafungin(J2248)*, Micafungin, Mycamine
Code J2248
Billing unit 1 MG Payment limit $0.180/unit NDC-Crosswalk 35
Quarter Q3 2026
RxCUI Atlas Trace the drug concept →
⚠ An NDC↔HCPCS crosswalk and a published payment limit do not guarantee payer coverage or payment. Always verify the current payer policy and claim format before billing.
🗂️ Key billing facts
HCPCS codeJ2248
DescriptorInjection, micafungin sodium, 1 mg
Billing unit1 MG
Payment limit / unit$0.180
Est. ASP / unit$0.170 est.
Mapped NDCs35
Data periodQ3 2026
Last updated2026-09-20
💊 About Micafungin DRUG GUIDE
Micafungin treats serious infections caused by Candida, a type of yeast.
These include candidemia (Candida in the bloodstream), acute disseminated candidiasis, Candida peritonitis and abscesses, and esophageal candidiasis (infection of the food pipe).It is also used to prevent Candida infections in adults and children 4 months and older having a hematopoietic stem cell transplant.
It has not been shown to work against fungi other than Candida.
Clinical overview from our editorial drug guide for Micafungin. For billing reference, see the sections above.
🧾 Billing & reimbursement HCPCS · CMS · EFF. Q3 2026
📅 Payment limits effective Q3 2026 — from the CMS Medicare Part B Payment Limit File (revised quarterly).
Medicare payment limit / unit
$0.180
Est. ASP / unit
$0.170 est.
Est. after 2% sequester
$0.176
HCPCS dosage
1 MG
The CMS payment limit is the Medicare Part B drug allowance (ASP + 6%, statutory). After the 2% federal sequester the effective payment is ≈ ASP + 4.3%; estimated ASP = payment limit ÷ 1.06. Source: CMS Medicare Part B Payment Limit File (quarterly), Q3 2026.
Full HCPCS code details (official CMS record)
Long descriptionInjection, micafungin sodium, 1 mg
CoverageC — Carrier/MAC judgment
Pricing indicator51 — Drug — priced under the ASP methodology
Type of service1 — Medical care
BETOS-2O1E
ASC payment group—
Action codeN — No maintenance this year
Effective date2016-01-01
Date added2007-01-01
Source: CMS HCPCS Level II code file (imported via admin).
🧮 Dosing & billing-units calculator HCPCS UNITS
One billing unit of J2248 = 1 mg. Enter a regimen to convert dose → billing units and project a full course.
Billing units = dose ÷ HCPCS unit size. Most payers require whole units — round per the payer's policy. “Est. Medicare pay” uses the current payment limit. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (JZ when none is discarded) where allowed. Always verify payer-specific rounding before billing.
🔁 NDCs that bill under J2248 WITH EST. MEDICARE PAY
35 NDCs map to J2248. Bill units = how many HCPCS units one package represents. Est. pay / pkg = payment limit ($0.180/unit) × that package's bill units.
| NDC (11-digit) | Drug | Labeler | Package | Strength | Bill units | Est. pay / pkg | NADAC / unit | Status | Source |
|---|---|---|---|---|---|---|---|---|---|
| 00143-9361-01 | Micafungin 50 mg/1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Hikma | 1 VIAL in 1 CARTON (0143-9361-01) / 5 INJ... | 50 mg/1 | 50 | $9.00 | — | ● Active | CMS + PDAC |
| 00143-9362-01 | Micafungin 100 mg/1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Hikma | 1 VIAL in 1 CARTON (0143-9362-01) / 5 INJ... | 100 mg/1 | 100 | $18.00 | — | ● Active | CMS + PDAC |
| 00469-3211-10 | Mycamine | Astellas | — | — | 1,000 | $180.00 | — | — | CMS + PDAC |
| 00469-3250-10 | Mycamine Micafungin sodium 10 mg/mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Astellas | 10 VIAL, SINGLE-DOSE in 1 CARTON (0469-325... | 10 mg/mL | 500 | $90.00 | — | Obsolete | CMS + PDAC |
| 16714-0164-10 | Micafungin Sodium | Northstar | — | — | 500 | $90.00 | — | — | CMS + PDAC |
| 16714-0301-10 | Micafungin Sodium | Northstar | — | — | 1,000 | $180.00 | — | — | CMS + PDAC |
| 25021-0190-10 | Micafungin 50 mg/5mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Sagent | 1 VIAL in 1 CARTON (25021-190-10) / 5 mL... | 50 mg/5mL | 50 | $9.00 | — | ● Active | CMS + PDAC |
| 25021-0190-11 | Micafungin 50 mg/5mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Sagent | 10 VIAL in 1 CARTON (25021-190-11) / 5 mL... | 50 mg/5mL | 500 | $90.00 | — | ● Active | CMS + PDAC |
| 25021-0190-12 | Micafungin 50 mg/5mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Sagent | 20 VIAL in 1 CARTON (25021-190-12) / 5 mL... | 50 mg/5mL | 1,000 | $180.00 | — | ● Active | CMS + PDAC |
| 25021-0191-10 | Micafungin 100 mg/5mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Sagent | 1 VIAL in 1 CARTON (25021-191-10) / 5 mL... | 100 mg/5mL | 100 | $18.00 | — | ● Active | CMS + PDAC |
| 25021-0191-11 | Micafungin 100 mg/5mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Sagent | 10 VIAL in 1 CARTON (25021-191-11) / 5 mL... | 100 mg/5mL | 1,000 | $180.00 | — | ● Active | CMS + PDAC |
| 25021-0191-12 | Micafungin 100 mg/5mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Sagent | 20 VIAL in 1 CARTON (25021-191-12) / 5 mL... | 100 mg/5mL | 2,000 | $360.00 | — | ● Active | CMS + PDAC |
| 60505-6119-05 | Micafungin | Apotex | — | — | 500 | $90.00 | — | — | CMS + PDAC |
| 60505-6120-06 | Micafungin | Apotex | — | — | 1,000 | $180.00 | — | — | CMS + PDAC |
| 63323-0728-10 | Micafungin 50 mg/1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Fresenius | 10 CARTON in 1 CARTON (63323-728-10) / 1... | 50 mg/1 | 500 | $90.00 | — | ● Active | CMS + PDAC |
| 63323-0729-10 | Micafungin 100 mg/1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Fresenius | 10 CARTON in 1 CARTON (63323-729-10) / 1... | 100 mg/1 | 1,000 | $180.00 | — | ● Active | CMS + PDAC |
| 63323-0729-12 | Micafungin 100 mg/1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Fresenius | 10 CARTON in 1 CARTON (63323-729-12) / 1... | 100 mg/1 | 1,000 | $180.00 | — | ● Active | CMS + PDAC |
| 68462-0771-01 | MICAFUNGIN 10 mg/mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Glenmark | 1 VIAL in 1 CARTON (68462-771-01) / 5 mL... | 10 mg/mL | 50 | $9.00 | — | ● Active | CMS + PDAC |
| 68462-0771-10 | MICAFUNGIN 10 mg/mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Glenmark | 10 VIAL in 1 CARTON (68462-771-10) / 5 mL... | 10 mg/mL | 500 | $90.00 | — | ● Active | CMS + PDAC |
| 68462-0772-01 | MICAFUNGIN 20 mg/mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Glenmark | 1 VIAL in 1 CARTON (68462-772-01) / 5 mL... | 20 mg/mL | 100 | $18.00 | — | ● Active | CMS + PDAC |
| 68462-0772-10 | MICAFUNGIN 20 mg/mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Glenmark | 10 VIAL in 1 CARTON (68462-772-10) / 5 mL... | 20 mg/mL | 1,000 | $180.00 | — | ● Active | CMS + PDAC |
| 70377-0075-91 | MICAFUNGIN 10 mg/mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Biocon | 10 VIAL, SINGLE-DOSE in 1 CARTON (70377-07... | 10 mg/mL | 500 | $90.00 | — | ● Active | CMS + PDAC |
| 70377-0076-91 | MICAFUNGIN 20 mg/mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Biocon | 10 VIAL, SINGLE-DOSE in 1 CARTON (70377-07... | 20 mg/mL | 1,000 | $180.00 | — | ● Active | CMS + PDAC |
| 70594-0036-01 | Micafungin | Xellia | — | — | 50 | $9.00 | — | — | CMS + PDAC |
| 70594-0037-01 | Micafungin | Xellia | — | — | 100 | $18.00 | — | — | CMS + PDAC |
| 70710-1724-06 | Micafungin 10 mg/mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Zydus | 10 VIAL in 1 CARTON (70710-1724-6) / 5 mL... | 10 mg/mL | 500 | $90.00 | — | ● Active | CMS + PDAC |
| 70710-1725-01 | Micafungin 20 mg/mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Zydus | 1 VIAL in 1 CARTON (70710-1725-1) / 5 mL... | 20 mg/mL | 100 | $18.00 | — | ● Active | CMS + PDAC |
| 70710-1725-06 | Micafungin 20 mg/mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Zydus | 10 VIAL in 1 CARTON (70710-1725-6) / 5 mL... | 20 mg/mL | 1,000 | $180.00 | — | ● Active | CMS + PDAC |
| 71288-0028-11 | Micafungin 50 mg/5mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Meitheal | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-02... | 50 mg/5mL | 500 | $90.00 | — | ● Active | CMS + PDAC |
| 71288-0028-12 | Micafungin 50 mg/5mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Meitheal | 1 VIAL, SINGLE-DOSE in 1 CARTON (71288-028... | 50 mg/5mL | 50 | $9.00 | — | ● Active | CMS + PDAC |
| 71288-0029-11 | Micafungin 100 mg/5mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Meitheal | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-02... | 100 mg/5mL | 1,000 | $180.00 | — | ● Active | CMS + PDAC |
| 71288-0029-12 | Micafungin 100 mg/5mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Meitheal | 1 VIAL, SINGLE-DOSE in 1 CARTON (71288-029... | 100 mg/5mL | 100 | $18.00 | — | ● Active | CMS + PDAC |
| 72572-0427-01 | Micafungin | Civica, | — | — | 100 | $18.00 | — | — | CMS + PDAC |
| 42023-0230-10 | Micafungin 20 mg/mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Par | 10 VIAL, SINGLE-DOSE in 1 CARTON (42023-23... | 20 mg/mL | 100 | $18.00 | — | Obsolete | PDAC |
| 42023-0229-10 | Micafungin 10 mg/mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Par | 10 VIAL, SINGLE-DOSE in 1 CARTON (42023-22... | 10 mg/mL | 50 | $9.00 | — | Obsolete | PDAC |
NDC→HCPCS mappings come from the CMS ASP NDC-HCPCS crosswalk; additional DME MAC / DMEPOS mappings come from PDAC and are labeled separately. NADAC from CMS (weekly). “Status” reflects the product's marketing / obsolete flag in the NDC directory. Presence or absence here does not determine Medicare coverage. Linked NDCs open the full product page.
📊 Medicare utilization & spend CMS · PART B · 2026 (Q1)
Period
Total Part B spend
$13.4K
Claims
497
Beneficiaries
51
Spend / beneficiary
$262.70
Spend / claim
$26.96
Trend by period
Where J2248 ranks among Part B drugs · 2026 (Q1) · neighbors ±5
Total spending — #673 of 824
#668
RUCONEST J0596
$15.2K
#669
ACYCLOVIR SODIUM J0133
$14.7K
#670
PIPERACILLIN-TAZOBAC... J2543
$14.7K
#671
MULTIHANCE MULTIPACK A9578
$13.7K
#672
FLUDARABINE PHOSPHAT... J9185
$13.6K
#673
MICAFUNGIN(J2248)* J2248
$13.4K
#674
CORTROSYN* J0834
$13.2K
#675
IMIPENEM-CILASTATIN... J0743
$13.1K
#676
FOSCARNET SODIUM J1455
$12.6K
#677
SURGRAFT XT PER SQ C... Q4269
$12.3K
#678
TOBRAMYCIN SULFATE J3260
$12.3K
Total claims — #455 of 824
#450
RISPERDAL CONSTA* J2794
517
#451
ALBUMIN (HUMAN)* P9041
514
#452
BENDAMUSTINE HCL* J9033
507
#453
CEREZYME J1786
506
#454
IMLYGIC J9325
503
#455
MICAFUNGIN(J2248)* J2248
497
#456
ADSTILADRIN J9029
497
#457
XCELL AMNIO MATRIX P... Q4280
495
#458
EPICORD 1 SQ CM** Q4187
490
#459
IMJUDO J9347
489
#460
XIPERE J3299
487
Top Medicare Part B drugs by the selected metric. Click any drug to open its J-code page. Source: CMS Medicare Quarterly Part B Spending by Drug.
Full breakdown by period (2)
| Period | Total spend | Beneficiaries | Claims | $/beneficiary | $/claim |
|---|---|---|---|---|---|
| 2026 (Q1) | $13.4K | 51 | 497 | $262.70 | $26.96 |
| 2025 (Q1-Q4) | $119.6K | 273 | 3,851 | $438.19 | $31.06 |
Provider-administered (Part B) spend, calculated for the whole HCPCS code (CMS does not publish Medicare spend per individual NDC). Self-administered use is covered under Part D instead. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part B Spending by Drug (data.cms.gov), updated quarterly.
📈 Medicare Part B claims detail CMS PSPS · 2024
Calendar-year 2024 Medicare Part B fee-for-service activity for this HCPCS code, summed across all carriers, localities and specialties (CMS Physician/Supplier Procedure Summary). A “service” is one billed line/unit — not one claim — so counts run higher than claim counts.
Allowed charges
$122.3K
Medicare paid
$94.9K
Submitted services
1,167,936
Denial rate
62.9%
Allowed / service
$0.28
Submitted charges
$4.31M
Source: CMS Physician/Supplier Procedure Summary (PSPS), CY2024 — Medicare Part B carrier + DME fee-for-service claims (excludes Medicare Advantage). Figures are for the whole HCPCS code, which may cover uses beyond this drug. ⚠ CMS hides any figure covering fewer than 11 patients (a privacy rule), so totals — especially denials and low-volume codes — run a little low.
🗺️ Where J2248 is utilized CMS · BY PROVIDER · 2024
Medicare Part B services for this code by the rendering provider's state — 89,401 services across 2 states & territories in 2024 (CMS reports include DC and U.S. territories). Switch to per 100k to compare states fairly regardless of population. Hover or tap a state for its top ZIP codes.
Hover or tap a state to see its numbers + top ZIP codes.
Per-capita = services ÷ 2023 state population × 100,000 (so high-population states aren't automatically "hotter"). Counts reflect the provider's location, not the patient's. Providers with fewer than 11 patients are hidden by CMS for privacy, so totals run low and per-100k can be noisy in small states — read this as relative geography, not exact counts. Source: CMS Medicare Physician & Other Practitioners — by Provider and Service, 2024.
📊 What bills under J2248
J-codes are billing codes often used for drugs billed under the medical benefit. This connects the billing code to the NDC package records it covers, by ingredient and labeler.
NDC products by ingredient
NDC products by labeler
🗃️ Data sources & freshness
Every figure on this page is computed from public datasets. Here's what each section draws on and how current it is.
HCPCS code & descriptor
CMS HCPCS Level II code file
Loaded
Payment limit & billing unit
CMS Medicare Part B ASP Pricing File (quarterly)
Q3 2026 · as of 2026-09-20
NDC ↔ HCPCS crosswalk
CMS ASP NDC-HCPCS crosswalk + DMEPDAC (PDAC)
35 NDCs mapped
NADAC acquisition cost
CMS National Average Drug Acquisition Cost (weekly)
Not available for mapped NDCs
Utilization & spend
CMS Part B Spending by Drug · PSPS · Physician & Other Practitioners
Latest data year 2026
Figures are estimates for reference and may lag the source files. Always verify against the current CMS files and your payer's policy before submitting claims.
⚠️ Practical billing caveats
- A crosswalk is not coverage. An NDC mapping or a published payment limit does not guarantee a payer will cover or pay this code. Check the specific plan's policy.
- Units ≠ milligrams. Bill the number of HCPCS units (dose ÷ the code's unit size), not the milligram dose. Use the calculator above.
- Discarded drug. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (and JZ when nothing is discarded) where the payer allows.
- Rounding & partial units. Many payers require whole units; round per the payer's policy, not automatically up.
- The code can cover more than this drug. Some HCPCS codes span multiple products or strengths — confirm the exact code for the product administered.
- Figures lag. ASP limits change quarterly and utilization data are released with a delay. Verify against the current CMS files before billing.
❓ J2248 billing FAQ
What is HCPCS code J2248?
J2248 is a HCPCS Level II J-code used to bill Injection, micafungin sodium, 1 mg under Medicare Part B and most medical (not pharmacy) benefits.
What is the billing unit for J2248?
One unit of J2248 represents 1 MG. Report the number of units equal to the dose administered divided by 1 MG.
How many units of J2248 should I bill?
Divide the dose administered by the code's unit size (1 MG) to get the number of billing units, then round per your payer's policy. The calculator on this page converts a dose into billing units and projects a full course.
How much does Medicare pay for J2248?
The Medicare Part B payment limit is $0.180 per unit (Q3 2026), based on ASP + 6%. After the 2% sequester the effective payment is about $0.176 per unit. Payment limits are revised quarterly.
Which NDCs bill under J2248?
35 NDCs currently map to J2248 in the CMS ASP NDC-HCPCS crosswalk. See the NDC crosswalk table above for each product, package, billing units and estimated reimbursement.
Does a crosswalk mean J2248 is covered?
No. An NDC-to-HCPCS crosswalk and a published payment limit do not guarantee coverage or payment. Coverage depends on the payer, the diagnosis and the site of care — always verify the current policy before billing.
For professional billing reference only — verify against the current CMS files before submitting claims.